TLDN yields 666666.67% · JNJ yields 2.13%● Live data
📍 TLDN pulled ahead of the other in Year 1
Combined, TLDN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLDN + JNJ for your $10,000?
Telidyne Inc. primarily designs, produces, and sells transmission towers and related products used in high voltage electric power transmission and wireless communications. The company's electric transmission and wireless communications product lines include angle steel towers, steel pipe towers, and transmission cable towers constructed primarily of steel, aluminum, or other alloy materials. Its wireless communication towers comprise single-tube towers, 4-strut towers, and roof top towers for the 2G, 3G, and microwave market. The company's electric transmission towers support 35kv, 110kv, 220kv, and 500kv transmission lines. It also provides telecommunication equipment, scrap, and technical consulting services. Telidyne Inc. sells its tower products to prime contractors on large transmission projects for electric utility companies or telecommunications service providers developing and constructing projects for end customers. The company was formerly known as TEC Technology, Inc. and changed its name to Telidyne Inc. in April 2018. The company was founded in 2006 and is based in New York, New York.
Full TLDN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.